Breast Cancer Screening Market Estimated to Experience a Hike in Growth by 2020 – 2025 | Hologic, GE Healthcare, Siemen Healthineers

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis. The assumption is that early detection will improve outcomes. A number of screening tests have been employed, including clinical and self breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.

A clinical or self breast exam involves feeling the breast for lumps or other abnormalities. Medical evidence, however, does not support its use in women with a typical risk for breast cancer

The use of mammography in universal screening for breast cancer is controversial as it may not reduce all-cause mortality and for causing harms through unnecessary treatments and medical procedures. Many national organizations recommend it for most older women. In the United States screening mammography women at normal risk for breast cancer, is only recommended every two years in women between the ages of 50 and 74. Several tools are available to help target breast cancer screening to older women with longer life expectancies. Similar imaging studies can be performed with magnetic resonance imaging but evidence is lacking.

Get a Sample Report to understand the structure of the complete report (Including Full TOC, Table & Figures):
https://www.worldwidemarketreports.com/sample/317786

The new report offers a powerful combination of latest, in-depth research studies on the Breast cancer screening market. The authors of the report are highly experienced analysts and possess deep market knowledge. Some of the key players operating in this Report are: Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare, Canon Medical, Fujifilm, Metaltronica, Sino Medical-Device, IMS Srl

Earlier, more aggressive, and more frequent screening is recommended for women at particularly high risk of developing breast cancer, such as those with a confirmed BRCA mutation, those who have previously had breast cancer, and those with a strong family history of breast and ovarian cancer.

Abnormal findings on screening are further investigated by surgically removing a piece of the suspicious lumps (biopsy) to examine them under the microscope. Ultrasound may be used to guide the biopsy needle during the procedure. Magnetic resonance imaging is used to guide treatment, but is not an established screening method for healthy women.

Coronavirus (COVID-19) Impact Analysis:

The report includes the latest coverage of the impact of COVID-19 on the Breast cancer screening industry. The incidence has affected nearly every aspect of the business domain. The outbreak has drastically affected the current business landscape and, subsequently, manufacturers and buyers. This study evaluates the current scenario and predicts future outcomes of the pandemic on the global economy.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Mammography Screening
Breast Magnetic Resonance Imaging (MRI) Screening
Breast Ultrasound Screening

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital
Clinic

Get Customized Report in your Inbox within 24 hours, Pricise your requirements, here:
https://www.worldwidemarketreports.com/quiry/317786

Contact Us:

Mr. Shah
Worldwide Market Reports
Seattle, WA 98154,
U.S.
Email: sales@worldwidemarketreports.com

Worldwide Market Reports provides customized upon request. This report can be personalized to suit your needs. Please contact the research team to ensure you receive the report that fits your needs.

This release was published on openPR.